The European Commission defends its coronavirus vaccination strategy amid growing criticism in member states about the slow rollout of COVID-19 shots across the region of 450 million inhabitants.
Vaccination programs in the 27 nation-bloc have gotten off to a slow start and some EU members have been quick to blame the EU’s executive arm for a perceived failure of delivering the right amount of doses. In Finland, health authorities are reportedly unhappy that the country only received about 40,000 doses in December, instead of the 300,000 that were expected.
Facing a barrage of questions on vaccines during a news conference, EU Commission spokesman Eric Mamer says the main problem with the deployment of vaccination programs “is an issue of production capacity, an issue that everybody is facing.”
A nurse receives the Pfizer-Biontech coronavirus vaccine at the Helsinki University Hospital in Helsinki, Finland on December 27, 2020 (Alessandro RAMPAZZO / AFP)
“We have actually signed contracts that would allow member states to get access to 2 billion doses, largely enough to vaccinate the whole of the EU population,” he said.
— AP
Is our work important to you?
Does The Times of Israel give you valuable insight into Israel and the Jewish world? If so, please join The Times of Israel Community. For as little as $6/month, you will:
Join the Times of Israel Community
Join our Community
Already a member? Sign in to stop seeing this
You’re serious. We appreciate that!
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we come to work every day - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
comments